Drug Information

General Information
Drug ID
DR01286
Drug Name
Pentazocine
Synonyms
(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol; (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol; 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan; 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan; 2-(3,3-Dimethylallyl)cyclazocine; 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan; 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol; Algopent (free base); Fortal (TN); Fortalgesic; Fortalin; Fortral; Fortral (TN); Fortwin (TN); II-C-2; KF-1820; L-pentazocine; Lexir; Liticon; NIH 7958; Pentagin; Pentazocaine; Pentazocin; Pentazocina; Pentazocina [DCIT]; Pentazocine (JP15/USP/INN); Pentazocine [USAN:INN:BAN:JAN]; Pentazocine, Pentazocin, Sosegon, WIN 20228; Pentazocinum; Pentazocinum [INN-Latin]; Sosegon; Soseton; Sosigon; Talacen; Talacen (TN); Talwan; Talwin (TN); Talwin NX (TN); Talwin PX (TN); WIN 20228
Drug Type
Small molecular drug
Indication Moderate to severe pain [ICD11: MG30-MG3Z] Approved [1]
Therapeutic Class
Anesthetics
Structure
3D MOL 2D MOL
Formula
C19H27NO
Canonical SMILES
CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
InChI
InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1
InChIKey
VOKSWYLNZZRQPF-GDIGMMSISA-N
CAS Number
CAS 359-83-1
Pharmaceutical Properties Molecular Weight 285.4 Topological Polar Surface Area 23.5
Heavy Atom Count 21 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2
XLogP
3.3
PubChem CID
441278
PubChem SID
9625 , 7847564 , 7980275 , 16653171 , 36885150 , 46506363 , 48416392 , 50481298 , 57403610 , 103178693 , 103915561 , 129503949 , 131269077 , 134337666 , 135650806 , 137009739 , 160963997 , 162223165 , 175269404 , 175427242 , 179150379 , 198969176 , 223440607 , 223732563 , 226394929
ChEBI ID
CHEBI:7982
TTD Drug ID
D0W6DG
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Pentazocine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.